CLASS II Device recall · Reported 19 Oct 2016 · FDA Enforcement Report

TheraSphere(R) Yttrium-90 Class Microsphere Injection recalled

Biocompatibles U.K is recalling TheraSphere(R) Yttrium-90 Class Microsphere Injection TheraSphere¿ is indicated for, distributed in 17 states. The recall was initiated on 21 Sep 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 1599211, Expiry Date: 18SEP2015 (12 days after calibration)
Quantity recalled64 doses

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0078-2017
FDA event ID
75350
Recalling firm
Biocompatibles U.K, Farnham, N/A
Classification
Class II
Status
Terminated
Recall initiated
21 Sep 2015
FDA classified
13 Oct 2016
Reported
19 Oct 2016
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Labeling Errors

Timeline

21 Sep 2015Recall initiated by company
13 Oct 2016Classified by FDA+388 days
19 Oct 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

One mislabeled dose of TheraSphere¿ Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.

Product as listed by the FDA

TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere¿ is indicated for radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable HCC who can have placement of appropriately positioned hepatic arterial catheters.

Where it was distributed

Worldwide Distribution - US to CA, FL, IL, WI, IN, OR, PA, MA, NY, KY, TX, MI, MD, NV, WA, OH, MN, and Internationally to Germany, Turkey, Hong Kong, Italy, Portugal

CaliforniaFloridaIllinoisIndianaKentuckyMassachusettsMarylandMichiganMinnesotaNevadaNew YorkOhioOregonPennsylvaniaTexasWashingtonWisconsin

Questions about this recall

Why was it recalled?

One mislabeled dose of TheraSphere¿ Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.

Which lots are affected?

Lot 1599211, Expiry Date: 18SEP2015 (12 days after calibration)

Where was it sold?

Worldwide Distribution - US to CA, FL, IL, WI, IN, OR, PA, MA, NY, KY, TX, MI, MD, NV, WA, OH, MN, and Internationally to Germany, Turkey, Hong Kong, Italy, Portugal

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biocompatibles U.K

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIVarithena (polidocanol injectable foam) Administration Pack recalledVarithenaBiocompatibles U.KOtherNationwide

Other Heart & Vascular Devices recalls

All 6,217